Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
VILNIUS, LT, May 5, 2025 – (ACN Newswire) – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral Clearance Studies (VCS) capabilities. This strategic growth follows the opening of Northway Biotech’s new Gene Therapy Center with dedicated cGMP
VILNIUS, LT, May 5, 2025 – (ACN Newswire) – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral Clearance Studies (VCS) capabilities. This strategic growth follows the opening of Northway Biotech’s new Gene Therapy Center with dedicated cGMP facilities for virus-related projects.With six newly established…
Read More
About Author
